Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Dermatologic Therapy|March 18, 2011
Therapeutic hotline. Genetic variations in the androgen receptor gene and finasteride response in women with androgenetic alopecia mediated by epigeneticsSharon Keene, Andy GorenDermatologic Therapy|August 30, 2018
Minoxidil in the treatment of androgenetic alopeciaAndy Goren, Ty NaccaratoDermatologic Therapy|August 20, 2013
In vitro evaluation of a novel topical cream for vitiligo and psoriasis that selectively delivers NB-UVB therapy when exposed to sunlightJohn McCoy, Andy Goren, Torello LottiDermatologic Therapy|April 30, 2014
Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopeciaJanet Roberts, Nisha Desai, John McCoy, et al.Journal of Cosmetic Dermatology|December 18, 2019
Novel topical formulation applied to the nipple-areola complex improves female orgasmMichael Krychman, Andy Goren, Len Brandt, et al.Expert Opinion on Pharmacotherapy|November 4, 2014
Topical cream delivers NB-UVB from sunlight for the treatment of vitiligoXingang Wang, John McCoy, Torello Lotti, et al.Medical Hypotheses|July 30, 2020
Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS)Flavio A Cadegiani, Andy Goren, Carlos G WambierMedical Hypotheses|August 8, 2020
Are night shift workers at an increased risk for COVID-19?Rachel K Lim, Carlos G Wambier, Andy GorenDermatologic Therapy|May 23, 2014
Acute telogen effluvium onset event is associated with the presence of female androgenetic alopecia: potential therapeutic implicationsNicolas Perez-Mora, Andy Goren, Carlos Velasco, et al.BMJ Case Reports|February 27, 2021
Potential risk for developing severe COVID-19 disease among anabolic steroid usersFlavio Cadegiani, Erica M Lin, Andy Goren, et al.Pageof 6